Skip to main content
SpringerLink
Log in

Merck & Co's live, oral, pentavalent rotavirus vaccine [Rotateq] has been awarded prequalification status by WHO.

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Merck & Co. Inc.ROTATEQ (Rm) Receives WHO Pre-qualification. Media Release: 11 Oct 2008. Available from: URL: http://www.merck.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merck & Co's live, oral, pentavalent rotavirus vaccine [Rotateq] has been awarded prequalification status by WHO.. Pharmacoecon. Outcomes News 564, 10 (2008). https://doi.org/10.2165/00151234-200805640-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805640-00028

Keywords

Search

Navigation